Table 2. . ASXL1 accompanying mutations.
| ASXL1 M (n = 22) | ASXL1 W (n = 66) | p-value | |
|---|---|---|---|
| ASXL1 | – | – | – |
| EZH2 | 2 | 2 | 0.259 |
| IDH1 | 3 | 3 | 0.162 |
| IDH2 | 3 | 2 | 0.097 |
| TET2 | 1 | 8 | 0.440 |
| CBL | 2 | 2 | 0.259 |
| FLT3 | 0 | 4 | 0.568 |
| NRAS | 4 | 10 | 0.743 |
| PTPN11 | 2 | 5 | 1 |
| KRAS | 1 | 3 | 1 |
| CEBPA | 2 | 4 | 0.637 |
| ETV6 | 6 | 3 | 0.007 |
| GATA2 | 2 | 7 | 1 |
| NPM1 | 0 | 7 | 0.185 |
| RUNX1 | 9 | 6 | 0.002 |
| SF3B1 | 0 | 7 | 0.185 |
| SRSF2 | 3 | 1 | 0.047 |
| U2AF1 | 11 | 18 | 0.067 |
| TP53 | 2 | 13 | 0.338 |
| WT1 | 0 | 5 | 0.325 |
| PHF6 | 3 | 1 | 0.047 |
| SETBP1 | 7 | 6 | 0.016 |
M: Mutated; W: Wild-type. Genes mutated in fewer than four patients are not listed.